TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from HCA Healthcare ( (HCA) ) is now available.
On October 31, 2025, HCA Inc., a subsidiary of HCA Healthcare, completed a significant financial transaction by issuing $3.25 billion in senior notes. This issuance, which includes notes maturing between 2030 and 2055, is expected to impact the company’s financial operations by providing additional capital, potentially influencing its market positioning and stakeholder interests.
The most recent analyst rating on (HCA) stock is a Buy with a $525.00 price target. To see the full list of analyst forecasts on HCA Healthcare stock, see the HCA Stock Forecast page.
Spark’s Take on HCA Stock
According to Spark, TipRanks’ AI Analyst, HCA is a Outperform.
HCA Healthcare’s overall stock score is driven by strong technical analysis and positive earnings call results, reflecting robust financial performance and upward guidance revision. However, financial risks due to high leverage and negative equity slightly temper the score. The valuation is fair, supporting the company’s growth potential.
To see Spark’s full report on HCA stock, click here.
More about HCA Healthcare
HCA Healthcare is a prominent entity in the healthcare industry, primarily focusing on providing a range of healthcare services. The company operates a network of hospitals and healthcare facilities, catering to a broad market that includes patients and medical professionals.
Average Trading Volume: 1,268,012
Technical Sentiment Signal: Buy
Current Market Cap: $109.2B
For detailed information about HCA stock, go to TipRanks’ Stock Analysis page.